Загрузка...
Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases
There are an estimated 10 000 monogenic diseases affecting tens of millions of individuals worldwide. The application of CRISPR/Cas genome editing tools to treat monogenic diseases is an emerging strategy with the potential to generate personalized treatment approaches for these patients. CRISPR/Cas...
Сохранить в:
| Опубликовано в: : | J Biomed Res |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Editorial Department of Journal of Biomedical Research
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8038532/ https://ncbi.nlm.nih.gov/pubmed/33402545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.34.20200105 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|